Skip to main content

Table 1 Comparison of general demographic features and lipid profiles between patients with coronary heart disease (CHD) and healthy controls (control)

From: Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China

Characteristic CHD (n = 238) Control (n = 236) t (χ2) P-value
Nationality (Li/Han) 112/126 120/116 0.681 0.409
Sex (male/female) 138/100 119/117 2.728 0.099
Age (years) 62.56 ± 12.34 60.76 ± 11.04 1.674 0.095
Systolic pressure (mmHg) 134.07 ± 21.54** 128.50 ± 14.61 29.204 0.000
Diastolic pressure (mmHg) 78.94 ± 11.71** 77.56 ± 7.87 13.18 0.000
Non-smoker/smoker 77/161 59/177 3.131 0.077
Non-drinker/drinker 46/192 63/173 3.632 0.057
FBS (mmol/L) 5.92 ± 1.51** 5.65 ± 0.47 2.66 0.008
TC (mmol/L) 4.95 ± 0.96* 4.79 ± 0.75 2.024 0.044
TG (mmol/L) 1.47 ± 1.05** 1.18 ± 0.73 3.542 0.000
HDL-C (mmol/L) 1.06 ± 0.34** 1.28 ± 0.30 −7.441 0.000
LDL-C (mmol/L) 3.08 ± 0.83** 2.82 ± 0.72 3.709 0.000
ApoAI (g/L) 1.16 ± 0.36** 1.32 ± 0.35 −4.936 0.000
ApoB (g/L) 1.04 ± 0.24** 0.87 ± 0.17 8.732 0.000
Lp(a) (mg/L) 257.41 ± 189.07* 217.44 ± 165.27 2.451 0.015
  1. Data are expressed as mean ± SD. FBS Fasting blood sugar, TC Total cholesterol, TG Triglyceride, HDL-C High density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol, ApoAI Lipoprotein AI, ApoB Lipoprotein B; Lp(a) Lipoprotein a, CHD Coronary heart disease. *P < 0.05, **P < 0.01, CHD patients versus healthy controls using χ2 test or t-test